Code Clarity

How to reduce confusion, encourage good record-keeping and stay complaint when briefing reps about call rates.

Sensational language, Mail article...yet no breach for GSK! Rina & Jean discuss why (Case AUTH/3691/9/22 ). A must listen for your comms team!

A LinkedIn poll recently confirmed that a compliance award could be based on bold ideas... Rina & Jean discuss why, what and how compliance can be celebrated alongside creativity. One for you and your agencies!

A recent case ruling (Case AUTH/3656/6/22 ) might leave you worried but we have three tips on how these interviews can be done well AND compliantly.

Our recent LinkedIn poll suggests 90% believe pharma's agencies should be Code-trained. Listen to our 3 top tips about the why , what and how representing best practice for ALL agencies.

Rina & Jean chat about how the PMCPA ruled ( Case AUTH/3662/6/22 ) for a case about dynamic content generated from sharing buttons. Can they move? Should they be certified? Or simply checked?

Aargh with no definition of a promotional claim in the ABPI Code AND a terrible definition for a promotional aid, is it any wonder we are confused? Rina & Jean suggest a clear solution (after a little bit of moaning). See our comments and please send yours by 29 Feb 24, link here ).

Rina & Jean discuss the proposed change in the 2024 Code for signatories requiring validation. Our top tips? Start PLANNING now, list out TASKS and COMMENT on the changes (see our comments and please send yours by 29 Feb 24, link here ).

Rina & Jean reflect on all the great discussion from the Code Clarity Conference and what comments could be made on the upcoming PMCPA consultation.

Deaghlan O'Hagan joins Rina to discuss the why, who and what of anon complaints, covering 3 pain points and potential solutions.

Complaints about "garbage" need to be specific! Jean covers Case AUTH/3696/10/22 and why SOBI were ruled not in breach.

Sick of long e-sales aids that contain too much info about clinical trials? Is this less or more of a compliance risk? Listen as we suggest practical solutions.

Rina & Jean discuss some myths (please let us know if you think of others). We will be putting these to Alex Fell (Director, PMCPA) at our Annual Conference.

Rina & Jean cover the recent ruling in Case AUTH/3701/10/22 (Astellas v Janssen) and discuss pharma providing nurse support, patient support programmes and inducements to individuals.

When it comes to pharma materials, we know our intent vs the impression to readers can be different! This can lead to: not getting the right message across difficulty getting engagement from the right audience the risk of saying something that could be harmful or against the rules Pharma can learn so much from Virginia Chachati - a pharmacist, medical writer and social media clinical content creat...

The topic of Disease Awareness always produces a lot of questions. We tackle some of them in this podcast. The case mentioned is case AUTH/3652/5/22.

Rina & Jean chat about how the venue and signage for UK pharma meetings can give a misleading impression. Case discussed is Case AUTH/3644/5/22 & AUTH/3694/10/22.

Patient case studies can be used really well in a variety of ways by different functions within pharma. Case mentioned is Case AUTH/3503/4/21. Further information in this article: https://globalforum.diaglobal.org/issue/may-2023/patient-case-studies-when-and-how-to-use-them/

Who, why, when and how should UK pharma compliantly engage patients to provide a range of services? We provide clarity in just a few minutes.

Rina & Jean discuss why and how medical education could mention medicine - the pros and the cons, mentioning the results of a LinkedIn poll and Case AUTH/3244/9/19.

How should we handle questions like this? Say no (there could be cake involved!!!)? Or say yes? Which questions should we be asking to be helpful, constructive and compliant?

Pharma feel nervous when engaging social media influencers, even though they can have a phenomenal impact. There's a lot to consider, so Rina & Jean chat through top-line principles so you can start gaining compliance confidence.

Rina & Jean discuss why, who, what and how email consent can comply with the ABPI Code.

What are the FIVE scenarios for when the UK Code applies to Global? Why is this important?

Rina and Jean discuss a no breach of the ABPI Code for Teva for how their website was accessed (Case 3641/4/22).